Dynamics of anti-M antibody response in a mouse model following intranasal infection with group A Streptococcus M-18

References

1. Babu G. P., Saraswathi N. P., John T. J. 1992; T-lymphocyte mediated injury of B cells in dual aetiology of diabetes mellitus in Swiss albino mouse. Indian J Exp Biol 30:769–774
   [Google Scholar]
2. Bessen D., Fischetti V. A. 1990; Synthetic peptide vaccine against mucosal colonization by group A streptococci.1. Protection against a heterologous M serotype with shared C repeat region epitopes. J Immunol 145:1251–1256
   [Google Scholar]
3. Bradley A. 2002; Mining the mouse genome. Nature 420:512–514 [CrossRef]
   [Google Scholar]
4. Cunningham M. 2000; Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13:470–511 [CrossRef]
   [Google Scholar]
5. Dale J. B., Simmons M., Chiang E. C., Chiang E. Y. 1996; Recombinant octavalent group A streptococcal M protein vaccine. Vaccine 14:944–948 [CrossRef]
   [Google Scholar]
6. Dale J. B., Chiang E. Y., Liu S., Courtney H. S., Hasty D. L. 1999; New protective antigen of group A streptococci. J Clin Invest 103:1261–1268 [CrossRef]
   [Google Scholar]
7. Fischetti V. A., Bessen D. 1998; Effect of mucosal antibodies to M protein on colonization by group A streptococci. In Molecular Mechanisms of Microbial Adhesion pp 128–142 New York, NY: Springer;
   [Google Scholar]
8. Hall M. A., Stroop S. D., Hu M. C., Walls M. A., Reddish M. A., Burt D. S., Lowell G. H., Dale J. B. 2004; Intranasal immunization with multivalent group A streptococcal vaccine protects mice against intranasal challenge infections. Infect Immun 72:2507–2512 [CrossRef]
   [Google Scholar]
9. Harrell W. K., Ashworth K., Britt L. E., Gorge J. R., Gray S. B., Green J. H., Gross H., Johnson J. E. 1982; Preparation of antisera for M types of groups A streptococci. In Procedure Manual for Production of Bacterial, Fungal and Parasitic Reagent pp 63–64 Atlanta, GA: Microbiological Reagents Unit, Centers for Disease Control & Prevention;
   [Google Scholar]
10. Holm S. E. 1996; Invasive group A streptococcal infections. N Engl J Med 335:590–591 [CrossRef]
    [Google Scholar]
11. Huber S. A., Cunningham M. W. 1996; Streptococcal M protein peptide with similarity to myosin induces CD4+ T cell-dependent myocarditis in MRL/++ mice and induces partial tolerance against coxsackie viral myocarditis. J Immunol 156:3528–3534
    [Google Scholar]
12. Jebamani S., Alice K., Jeyachand J., Chandi S. M., Krishnaswami S., Brahmadathan K. N. 1998; Pharyngeal colonization, ADNB response and development of cardiac lesions following intranasal inoculation with group A beta haemolytic streptococcus M type 18. Indian J Exp Biol 36:292–297
    [Google Scholar]
13. Jebamani S., Kuruvilla A., Chandi S., Krishnaswami S., Brahmadathan K. N. 1999; Effects of intranasal challenge with group A beta haemolytic streptococcus M type 49 in Swiss albino mice. Indian J Exp Biol 37:971–975
    [Google Scholar]
14. Ji Y., Carlson B., Kondagunta A., Cleary P. 1997; Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A streptococci. Infect Immun 65:2080–2087
    [Google Scholar]
15. Jones K. F., Fischetti V. A. 1988; The importance of the location of antibody binding on the M6 protein for opsonization and phagocytosis of group A M6 streptococcus. J Exp Med 167:1114–1123 [CrossRef]
    [Google Scholar]
16. Kaplan E. L. 1991; The resurgence of group A streptococcal infections and their sequelae. Eur J Clin Microbiol Infect Dis 10:55–57 [CrossRef]
    [Google Scholar]
17. Koshi G., Benjamin V., Cherian G. 1981; Rheumatic fever and rheumatic heart disease in rural South Indian children. Bull World Health Organ 59:599–603
    [Google Scholar]
18. Kotloff K. L., Corretti M., Palmer K., Campbell J. D., Reddish M. A., Hu M. C., Wasserman S. S., Dale J. B. 2004; Safety and immunogenicity of a recombinant multivalent group A streptococcal vaccine in healthy adults: phase 1 trial. JAMA 292:709–715 [CrossRef]
    [Google Scholar]
19. Medaglini D., Pozzi G., King T. P., Fischetti V. A. 1995; Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization. Proc Natl Acad Sci 92:6868–6872 [CrossRef]
    [Google Scholar]
20. Padmavathi S. 1995; Present status of rheumatic fever and rheumatic heart disease in India. Indian Heart J 47:395–398
    [Google Scholar]
21. Padmavathi S. 2001; Rheumatic fever and rheumatic heart disease in India at the turn of the century. Indian Heart J 53:35–37
    [Google Scholar]
22. Pozzi G., Oggioni M. R., Manganelli R., Fischetti V. A. 1992; Expression of M6 protein gene of Streptococcus pyogenes in Streptococcus gordonii after chromosomal integration and transcriptional fusion. Res Microbiol 143:449–457 [CrossRef]
    [Google Scholar]
23. Smoot J. C., Barbian K. D., Van Gompel J. J. & 15 other authors; 2002; Genome sequence and comparative microarray analysis of serotype M 18 group A S treptococcus strains associated with acute rheumatic fever outbreaks. Proc Natl Acad Sci U S A 99:4668–4673 [CrossRef]
    [Google Scholar]
24. Veasy L. G., Tani L. Y., Daly J. A., Korgenski K., Miner L., Bale J., Kaplan E. L., Musser J. M., Hill H. R. 2004; Temporal association of the appearance of mucoid strains of Streptococcus pyogenes with a continuing high incidence of rheumatic fever in Utah. Pediatrics 113:e168–e172 [CrossRef]
    [Google Scholar]
25. Wannamaker L. W. 1970; Differences between streptococcal infections of the throat and of the skin. N Engl J Med 282:23–31 [CrossRef]
    [Google Scholar]